Literature DB >> 32975673

A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis.

Domenico Plantone1, Catello Vollono2, Matteo Pardini3, Guido Primiano2, Virxhina Myftari4, Francesca Vitetta5, Patrizia Sola5, Massimiliano Mirabella2, Diana Ferraro4,5.   

Abstract

BACKGROUND: Pain is one of the most disabling symptoms in multiple sclerosis. Chronic pain in multiple sclerosis is often neuropathic in nature, although a clear-cut distinction with nociceptive pain is not easy.
OBJECTIVE: The aim of our study was to analyze the MRIs of multiple sclerosis patients with chronic pain in order to explore possible associations with lesion sites, on a voxel-by-voxel basis.
MATERIALS AND METHODS: We enrolled patients aged > 18 years with multiple sclerosis in accordance with the 2010 McDonald criteria. Patients meeting criteria for persistent pain (frequent or constant pain lasting > 3 months) were included in the "pain group". The other patients were included in the "no pain group". We outlined lesions on FLAIR MRI scans using a semi-automated edge finding tool. To detect the association between lesion localization and persistent pain, images were analysed with the voxel-based lesion symptom mapping methods implemented in the (nonparametric mapping software included into the MRIcron.
RESULTS: We enrolled 208 MS patients (140 F, mean age 55.2 ± 9.4 years; 176 RR, 28 progressive MS; mean EDSS 2.0 + 2.0). Pain group included 96 patients and no pain group 112 patients. Lesions of the right dorsolateral prefrontal area were significantly more prevalent in patients without pain, whereas periventricular posterior lesions were significantly more prevalent in patients with persistent pain.
CONCLUSION: Our data suggest a role of the right dorsolateral prefrontal cortex in the modulation of pain perception and in the occurrence of chronic pain in MS patients. Our data also support a hemispheric asymmetry in pain perception and modulation.

Entities:  

Keywords:  Multiple sclerosis; Neuropathic pain; Pain

Year:  2020        PMID: 32975673     DOI: 10.1007/s10072-020-04745-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  6 in total

Review 1.  [Dementia and pain].

Authors:  Reinhold Schmidt; Michael Bach; Peter Dal-Bianco; Peter Holzer; Aga Pluta-Fuerst; Eva Assem-Hilger; Anita Lechner; Margherita Cavalieri; Bernhard Haider; Helena Schmidt; Georg Pinter; Wolfgang Pipam; Elisabeth Stögmann; Christian Lampl; Rudolf Likar
Journal:  Neuropsychiatr       Date:  2010

2.  Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy.

Authors:  V Spallone; R Morganti; C D'Amato; C Greco; L Cacciotti; G A Marfia
Journal:  Diabet Med       Date:  2012-05       Impact factor: 4.359

3.  A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore).

Authors:  Augusto Caraceni; Tito R Mendoza; Emanuela Mencaglia; Claudio Baratella; Katherine Edwards; Maria Joao Forjaz; Cinzia Martini; Ronald C Serlin; Franco de Conno; Charles S Cleeland
Journal:  Pain       Date:  1996-04       Impact factor: 6.961

4.  Development and validation of the Neuropathic Pain Symptom Inventory.

Authors:  Didier Bouhassira; Nadine Attal; Jacques Fermanian; Haiel Alchaar; Michèle Gautron; Etienne Masquelier; Sylvie Rostaing; Michel Lanteri-Minet; Elisabeth Collin; Jacques Grisart; François Boureau
Journal:  Pain       Date:  2004-04       Impact factor: 6.961

5.  The Italian Pain Questionnaire.

Authors:  G De Benedittis; R Massel; R Nobili; A Pieri
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

6.  Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases.

Authors:  Luca Padua; Chiara Briani; Stefano Jann; Eduardo Nobile-Orazio; Costanza Pazzaglia; Alberto Morini; Mauro Mondelli; Palma Ciaramitaro; Guido Cavaletti; Dario Cocito; Raffaella Fazio; Lucio Santoro; Francesca Galeotti; Marinella Carpo; Rosaria Plasmati; Luana Benedetti; Angelo Schenone; Paolo Marchettini; Giorgio Cruccu
Journal:  Neurol Sci       Date:  2009-02-06       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.